GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $356,000 | -83.6% | 5,221 | -93.0% | 0.00% | -50.0% |
| Q4 2021 | $2,177,000 | +45.3% | 74,400 | +26.5% | 0.00% | +100.0% |
| Q3 2021 | $1,498,000 | -66.9% | 58,793 | -54.5% | 0.00% | -75.0% |
| Q2 2021 | $4,525,000 | +370.4% | 129,200 | +447.5% | 0.00% | +300.0% |
| Q1 2021 | $962,000 | -3.4% | 23,600 | +2.6% | 0.00% | 0.0% |
| Q4 2020 | $996,000 | +9.1% | 23,000 | +22.2% | 0.00% | 0.0% |
| Q3 2019 | $913,000 | -73.3% | 18,817 | -71.1% | 0.00% | -75.0% |
| Q2 2019 | $3,419,000 | -42.3% | 65,000 | -42.0% | 0.00% | -42.9% |
| Q1 2019 | $5,928,000 | +6.5% | 112,007 | -17.4% | 0.01% | -12.5% |
| Q4 2018 | $5,564,000 | +63.8% | 135,522 | +51.7% | 0.01% | +100.0% |
| Q3 2018 | $3,396,000 | -16.4% | 89,360 | -0.5% | 0.00% | -33.3% |
| Q2 2018 | $4,060,000 | +76.9% | 89,828 | +54.0% | 0.01% | +100.0% |
| Q4 2017 | $2,295,000 | +11375.0% | 58,330 | +4760.8% | 0.00% | – |
| Q2 2016 | $20,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |